Amneal Pharmaceuticals, Inc. AMRX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s invested capital?
- Amneal Pharmaceuticals, Inc. (AMRX) reported invested capital of $2.33B in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s invested capital increased by 16.7% year-over-year, from $1.99B to $2.33B.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s invested capital has grown at a -4.0% compound annual growth rate (CAGR), from $2.87B to $2.34B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).